New hope for bipolar depression? pramipexole trial targets anhedonia
Symptom relief
Not yet recruiting
This Phase 3 trial tests whether pramipexole, a dopamine-boosting drug, can ease anhedonia (loss of pleasure) in people with bipolar depression. 126 participants will receive either pramipexole or a placebo alongside their usual mood stabilizer for 6 weeks. The study aims to impr…
Phase: PHASE3 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC